Literature DB >> 2196238

Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.

M Weller1, R Clausen, M Bresgen, K Heimann, P Wiedemann.   

Abstract

This study examines a possible immunological contribution to the development of proliferative intraocular disorders (PID) with traction retinal detachment. We analysed 24 periretinal membranes and 35 vitreous aspirates from patients with idiopathic proliferative vitreoretinopathy (PVR), traumatic PVR, and proliferative diabetic retinopathy (PDR). Lymphocytes and complement factor C3 deposits could not be detected in any of the membrane specimens. IgG was present in all but one of the PVR membranes but in less than half of the PDR specimens and there to a lesser extent. The IgG immunoreactivity was not collocalized with macrophages but instead located to the extracellular matrix. The intravitreal levels of IgG (ELISA) and protein were elevated in PID but the range of these biochemical changes was so wide that there were no significant differences of the IgG levels between the single types of PID. Using electrophoresis and Western blotting, C3 was detected in normal and pathologic vitreous but smaller C3 fragments indicative of C3 breakdown were only found in PID.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196238     DOI: 10.1007/bf00159864

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  14 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 2.  Immunochemical analysis of periretinal membranes. Review and outlook.

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  Dev Ophthalmol       Date:  1989

3.  Gel gradient electrophoresis, isoelectric focusing and two-dimensional techniques in horizontal, ultrathin polyacrylamide layers.

Authors:  A Görg; W Postel; R Westermeier; E Gianazza; P G Righetti
Journal:  J Biochem Biophys Methods       Date:  1980-11

4.  The pathophysiology of proliferative vitreoretinopathy.

Authors:  P Wiedemann; M Weller
Journal:  Acta Ophthalmol Suppl       Date:  1988

Review 5.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

6.  Diagnostic cytopathology of ocular fluid specimens.

Authors:  W R Green
Journal:  Ophthalmology       Date:  1984-06       Impact factor: 12.079

7.  Vitrectomy. Clinical data and cytologic findings of vitrectomy specimens.

Authors:  L Laatikainen; A Tarkkanen; A Koivuniemi
Journal:  Int Ophthalmol       Date:  1985-03       Impact factor: 2.031

8.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

9.  [Role of macrophages and fibronectin in vitreoretinal proliferation].

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  J Fr Ophtalmol       Date:  1988       Impact factor: 0.818

10.  Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy.

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  Int Ophthalmol       Date:  1988-01       Impact factor: 2.031

View more
  3 in total

1.  The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.

Authors:  Hsi-Kung Kuo; Yi-Hao Chen; Faye Huang; Yi-Chan Wu; Jentaie Shiea; Pei-Chang Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

Review 2.  Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.

Authors:  Alicia J Jenkins; Maria B Grant; Julia V Busik
Journal:  Diabetologia       Date:  2022-02-11       Impact factor: 10.460

3.  Expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on proliferating vascular endothelial cells in diabetic epiretinal membranes.

Authors:  S Tang; K C Le-Ruppert; V P Gabel
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.